^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    CT101a

    i
    Other names: CT101a, cytokine-induced memory-like NK cells
    Associations

    News

    Trials
    Company:
    Shanghai Zeke Biotech, Zhejiang University
    Drug class:
    NK cell stimulant
    Related drugs:
    Associations

    News

    Trials
    almost1year
    NK Cell Therapy for AML (clinicaltrials.gov)
    P1, N=3, Terminated, Zhejiang University | N=18 --> 3 | Trial completion date: Jun 2025 --> Apr 2023 | Recruiting --> Terminated | Trial primary completion date: Dec 2024 --> Aug 2022; A new study is planed to replace the current study due to IP upgrade
    Enrollment change • Trial completion date • Trial termination • Trial primary completion date
    |
    CT101a